It is People Like Eric Lefkofsky who will Improve the Industry the Most in the Coming Years

Changes in Health

There are a lot of changes taking place in the healthcare industry today. With more technology than ever before, many people are starting to improve their overall quality of life greatly. Now is the time to invest money into this area to save lives in the future. One of the best new innovations in the industry is the rise of preventative medicine. This is where we can now prevent issues before they come up in the body. It requires a lot of technology to do this, but it is a great way to prevent illness and death later on in life.

Cost of Care

The biggest issue facing the medical industry today is the cost of care. Few people can afford to pay for a health issue if it comes up in their life. With that being said, health insurance costs are starting to increase rapidly as well. The middle class is being hurt in both areas financially.

The good news is that health treatment technology should lower the cost of care over a long period of time. With all of the changes that are going on, now is the time for people to take control of their health again. A lot of people struggle with their health today because they have poor lifestyle habits to learn more: click here.

Eric Lefkofsky

One of the leaders in the field of health about Eric Lefkofsky. He is passionate about the work that he does, and he wants to take the industry to a new level. He sees all of the opportunities that are available within this field to drive growth and innovation in the future.

With all of the changes that are happening in healthcare, it is vital for business leaders to have a vision of the future. Many business leaders are only concentrating on driving profits for the next quarter. It is people like Eric Lefkofsky who will improve the industry the most in the coming years.

He has a passion for helping others that few other people have. Not only that, but he is more interested in saving lives than making money.


Plenty of firms are striving to try and find the solution to cancer. In the past decade or so, one company Seattle Genetics, has been on the forefront in doing research on cancer. While speaking at a recent event, Dr. Clay Siegall the CEO of Seattle Genetics,I was awed with some of the initiatives that the company was focusing on as they advanced in the cancer therapy. The stock price at Seattle Genetics had almost tripled over the past five years, a sign that the company plays a significant role in that field.

Since he began his career in biomedical studies, the CEO of Seattle Genetics, Dr. Clay has shown the passion of trying to improve the lives of people who have cancer. He is currently serving as the president, CEO, and chairs the board of Seattle Genetics. Dr. Clay has held the CEO position since 2002. He co-founded the company in 1998 thus has over two decades of history with the firm. Since the company was started, Dr. Siegall has put in a lot of effort to take the cancer research and its therapies to patients to greater heights.

Dr. Clay’s role at Seattle Genetics

Besides being the president and CEO of Seattle Genetics, Dr. Clay plays a prominent role in the research and implementation of the outstanding results of research.

Dr. Clay Siegall’s primary responsibility as the CEO of Seattle Genetics

Dr. Clay’s primary responsibility as the CEO of Seattle Genetics is to oversee the growth of the company by providing good leadership and an enabling environment for research on cancer. That is besides giving his expertise on science to handle issues pertaining cancer.

Dr. Clay Siegall’s role in the cancer research community

Dr. Clay has contributed to the scientific society by publishing on the new research methodologies and findings. He has so far shared some in-depth information with the medical and scientific communities. He has over 70 articles that mainly touch on the cancer issue. He holds a position on the editorial boards of scientific magazines and is willing to allow other scientist research and publish their findings.